Apeiron Biologics' Loan

Apeiron Biologics raised a round of funding on August 28, 2017. Investors include European Investment Bank.

Apeiron is a private biotech company based in Vienna, Austria, engaged in innovative projects in immuno-oncology. Recently the most advanced project (immunotherapy of neuroblastoma) was granted market…

Articles about Apeiron Biologics' Loan: